Mutations in the desmin gene (i.e., C333S mutation) lead to the accumulation of granulo-filamentous desmin-positive aggregates and myopathy, which can be reduced by antioxidant treatment by up to 75% [72]. The gene discussed is DES; the disease is myopathy.